EGFR and retinoblastoma: In summary, these data suggest that prolonged treatment with palbociclib induces tumour re-wiring leading to increased expression of growth factor signalling which provides an alternate mitogenic cue in RB competent models which is sensitive to EGFR/ERBB inhibition.